Clinical Trial Update: Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes

View source ↗

Summary

A completed clinical trial evaluated shifting from twice-daily insulin glargine or detemir to once-daily insulin degludec in people with Type 1 diabetes mellitu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin detemir (insulin detemir)
• insulin degludec (insulin degludec)

Snippet

Sponsor: University of Padova | Conditions: Type 1 Diabetes Mellitus | Status: COMPLETED